Smith & Nephew SNATS Inc

Healthcare · Medical Devices

26.40$ -0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Smith & Nephew SNATS Inc (SNN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 3,097 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement SNN
Line item	Q3 15	Q4 15	Q1 16	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q4 24	Q2 25	Q4 25	Q2 26
Revenue	1,181	2,362	1,164	2,328	1,171	2,341	1,168	2,336	1,215	2,429	1,220	2,440	1,232	2,464	1,243	2,485	1,327	2,653	1,018	2,035	1,263	2,525	1,300	2,599	1,307	2,613	1,300	2,600	1,308	2,615	1,367	2,734	1,408	2,815	1,414	2,827	2,983	2,961	3,203	3,097
Cost of Revenue	289	577	316	632	320	640	302	603	323	645	327	653	323	645	324	648	342	683	323	646	368	735	403	806	354	708	387	773	374	747	418	836	411	818	427	853	878	870	1,087	901
Gross Profit	893	1,785	848	1,696	851	1,701	867	1,733	892	1,784	894	1,787	910	1,819	919	1,837	985	1,970	695	1,389	895	1,790	897	1,793	953	1,905	914	1,827	934	1,868	949	1,898	997	1,997	987	1,974	2,105	2,091	2,116	2,196
Research & Development	62	123	57	113	66	132	54	107	61	122	58	116	77	154	70	139	91	181	74	148	98	195	86	171	113	226	87	174	134	222	83	166	110	219	69	137	206	143	203	150
Selling, General & Administrative	1,235	1,379	0.0	1,298	1,298	1,272	605	1,317	718	56	650	650	546	56	640	1,166	641	56	1,069	1,069	–	352	–	1,163	–	376	–	1,213	–	376	–	1,315	–	1,337	–	1,360	1,378	1,425	1,265	–
Total Operating Expenses	809	1,596	673	1,339	472	1,257	663	1,319	631	1,264	711	1,415	677	1,328	715	1,418	790	1,574	701	1,394	738	1,490	766	1,554	754	1,551	796	1,585	902	1,660	822	1,623	931	1,847	830	1,646	1,776	1,662	1,751	1,748
Operating Income	233	189	199	357	257	444	207	414	236	520	186	372	302	491	210	419	281	396	-2.5	-5.0	219	300	120	239	237	354	121	242	212	208	138	275	204	150	164	328	329	429	365	448
Interest Expense	10	10	12	12	11	38	13	34	13	33	13	37	13	42	13	38	15	45	11	29	18	41	20	51	18	46	16	40	17	48	22	62	–	77	–	82	91	82	75	55
Pre-Tax Income	74	148	164	327	368	735	192	383	248	496	171	341	220	440	192	383	180	360	-17	-34	140	280	112	223	182	363	102	204	16	31	106	211	40	79	127	253	245	362	417	380
Income Tax Expense	17	33	43	86	96	192	30	59	27	53	34	67	26	51	37	74	35	69	67	-134	34	-68	9.0	18	22	44	14	27	7.5	-15	20	39	6.0	-12	20	39	47	69	85	77
Net Income	58	115	121	241	272	543	162	324	222	443	137	274	195	389	155	309	146	291	50	100	174	348	103	205	160	319	89	177	23	46	86	172	46	91	107	214	198	293	332	303
EBITDA	325	650	306	612	340	680	317	633	325	649	300	600	380	760	334	667	359	717	133	266	309	617	267	533	323	645	276	551	282	551	286	561	273	615	260	601	734	702	634	748

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings